Clinical Trial Update: GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial [Phase 2, Phase 3]

View source ↗

Summary

Pilot/Phase 2/3 trial evaluating GLP-1 receptor agonists after bariatric surgery is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GLP-1 receptor agonists

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Severe Obesity, Obesity | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION